In the last trading session, 2.73 million shares of the Regencell Bioscience Holdings Ltd (NASDAQ:RGC) were traded, and its beta was -0.58. Most recently the company’s share price was $6.10, and it changed around $1.45 or 31.18% from the last close, which brings the market valuation of the company to $79.36M. RGC currently trades at a discount to its 52-week high of $32.44, offering almost -431.8% off that amount. The share price’s 52-week low was $3.03, which indicates that the current value has risen by an impressive 50.33% since then. We note from Regencell Bioscience Holdings Ltd’s average daily trading volume that its 10-day average is 0.29 million shares, with the 3-month average coming to 165.28K.
Regencell Bioscience Holdings Ltd (NASDAQ:RGC) trade information
Instantly RGC has showed a green trend with a performance of 31.18% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 12.50 on recent trading dayincreased the stock’s daily price by 51.2%. The company’s shares are currently down -41.90% year-to-date, but still up 22.00% over the last five days. On the other hand, Regencell Bioscience Holdings Ltd (NASDAQ:RGC) is 10.11% up in the 30-day period. We can see from the shorts that 37382.0 shares have been sold at a short interest cover period of 0.36 day(s).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -60.65%.
RGC Dividends
Regencell Bioscience Holdings Ltd’s next quarterly earnings report is expected to be released in November.
BLACKROCK INC., with 0.0018% or 238.0 shares worth $800.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
